Drug Profile
Mesalazine rectal gel - Gentium
Alternative Names: 5-Aminosalicylic acid rectal gel - Axcan Pharma; 5-ASA rectal gel - Axcan Pharma; Canasa Rectal Gel; Mesalamine rectal gel; Salofalk Rectal GelLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Gentium
- Class Aminosalicylic acids; Anti-inflammatories; Antineoplastics; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ulcerative colitis
Most Recent Events
- 03 Feb 2014 Aptalis has been acquired by Forest Laboratories
- 25 Feb 2008 Axcan Pharma has been acquired by Texas Pacific Group
- 10 Aug 2006 Discontinued - Phase-III for Ulcerative colitis in Canada (Rectal)